Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureusDAVIS, Susan L; RYBAK, Michael J; AMJAD, Muhammad et al.Infection control and hospital epidemiology. 2006, Vol 27, Num 10, pp 1025-1031, issn 0899-823X, 7 p.Article

A factor analytic study of the cross-cultural adaptability inventoryDAVIS, Susan L; FINNEY, Sara J.Educational and psychological measurement. 2006, Vol 66, Num 2, pp 318-330, issn 0013-1644, 13 p.Article

Integrating patient satisfaction with a quality improvement programDAVIS, Susan-L; ADAMS-GREENLY, Margaret.JOURNAL OF NURSING ADMINISTRATION. 1994, Vol 24, Num 12, pp 28-31Article

Integrating patient satisfaction with a quality improvement programDAVIS, Susan-L; ADAMS-GREENLY, Margaret.JOURNAL OF NURSING ADMINISTRATION. 1994, Vol 24, Num 12, pp 28-31Article

Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15―20 mg/L Suggested by the Vancomycin Consensus GuidelinesKULLAR, Ravina; LEONARD, Steven N; DAVIS, Susan L et al.Pharmacotherapy. 2011, Vol 31, Num 5, pp 441-448, issn 0277-0008, 8 p.Article

Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patientsDAVIS, Susan L; VAZQUEZ, Jose A; MCKINNON, Peggy S et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 4, pp 568-573, issn 1060-0280, 6 p.Article

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil TherapyCASAPAO, Anthony M; DAVIS, Susan L; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2541-2546, issn 0066-4804, 6 p.Article

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective StudyKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Pharmacotherapy. 2011, Vol 31, Num 6, pp 527-536, issn 0277-0008, 10 p.Article

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Urban DetroitCHUA, Thea; MOORE, Carol L; PERRI, Mary B et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 7, pp 2345-2352, issn 0095-1137, 8 p.Article

Evaluation of Vancomycin Population Susceptibility Analysis Profile as a Predictor of Outcomes for Patients with Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureusCASAPAO, Anthony M; DAVIS, Susan L; MCROBERTS, John Paul et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4636-4641, issn 0066-4804, 6 p.Article

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration > 1 mg/L: A Matched Cohort StudyMURRAY, Kyle P; ZHAO, Jing J; DAVIS, Susan L et al.Clinical infectious diseases. 2013, Vol 56, Num 11, pp 1562-1569, issn 1058-4838, 8 p.Article

Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal InfectionsCASAPAO, Anthony M; KULLAR, Ravina; COSGROVE, Sara E et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4190-4196, issn 0066-4804, 7 p.Article

Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infectionsMOORE, Carol L; HINGWE, Ameet; DONABEDIAN, Susan M et al.International journal of antimicrobial agents (Print). 2009, Vol 34, Num 2, pp 148-155, issn 0924-8579, 8 p.Article

Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient CohortKULLAR, Ravina; DAVIS, Susan L; TAYLOR, Thomas N et al.Pharmacotherapy. 2012, Vol 32, Num 3, pp 195-201, issn 0277-0008, 7 p.Article

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested TargetsKULLAR, Ravina; DAVIS, Susan L; LEVINE, Donald P et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 975-981, issn 1058-4838, 7 p.Article

Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections : Clinical and Economic OutcomesDAVIS, Susan L; MCKINNON, Peggy S; HALL, Levi M et al.Pharmacotherapy. 2007, Vol 27, Num 12, pp 1611-1618, issn 0277-0008, 8 p.Article

Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumoniaDAVIS, Susan L; DELGADO, George JR; MCKINNON, Peggy S et al.Clinical infectious diseases. 2005, Vol 41, pp S136-S143, issn 1058-4838, SUP2Article

Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream InfectionCASAPAO, Anthony M; LEONARD, Steven N; DAVIS, Susan L et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 9, pp 4252-4259, issn 0066-4804, 8 p.Article

Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus BacteremiaKULLAR, Ravina; DAVIS, Susan L; KAYE, Keith S et al.Pharmacotherapy. 2013, Vol 33, Num 1, pp 3-10, issn 0277-0008, 8 p.Article

Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals : VANCOMYCINDAVIS, Susan L; SCHEETZ, Marc H; BOSSO, John A et al.Pharmacotherapy. 2013, Vol 33, Num 12, pp 1256-1263, issn 0277-0008, 8 p.Article

A latent profile analysis of college students' achievement goal orientationPASTOR, Dena A; BARRON, Kenneth E; MILLER, B. J et al.Contemporary educational psychology. 2007, Vol 32, Num 1, pp 8-47, issn 0361-476X, 40 p.Article